<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR141">
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Mandal</surname>
    <given-names>S</given-names>
   </name>
   <name>
    <surname>Prathipati</surname>
    <given-names>PK</given-names>
   </name>
   <name>
    <surname>Kang</surname>
    <given-names>GB</given-names>
   </name>
   <name>
    <surname>Zhou</surname>
    <given-names>Y</given-names>
   </name>
   <name>
    <surname>Yuan</surname>
    <given-names>Z</given-names>
   </name>
   <name>
    <surname>Fan</surname>
    <given-names>WJ</given-names>
   </name>
   <name>
    <surname>Li</surname>
    <given-names>QS</given-names>
   </name>
   <name>
    <surname>Destache</surname>
    <given-names>CJ</given-names>
   </name>
  </person-group>
  <article-title>Tenofovir alafenamide and and elvitegravir loaded nanoparticles for long-acting prevention of HIV-1 vaginal transmission</article-title>
  <source>AIDS</source>
  <year>2017</year>
  <volume>31</volume>
  <fpage>469</fpage>
  <lpage>476</lpage>
  <pub-id pub-id-type="doi">10.1097/QAD.0000000000001349</pub-id>
  <?supplied-pmid 28121666?>
  <pub-id pub-id-type="pmid">28121666</pub-id>
 </element-citation>
</ref>
